Wernicke’s encephalopathy in a malnourished surgical patient: a difficult diagnosis
© Busani et al.; licensee BioMed Central Ltd. 2014
Received: 11 April 2014
Accepted: 8 October 2014
Published: 14 October 2014
Wernicke’s encephalopathy is an acute neurological disorder resulting from thiamine deficiency mainly related to alcohol abuse. Severe thiamine deficiency is an emerging problem in non-alcoholic patients and it may develop in postoperative surgical patients with risk factors.
We reported a case of a 46 years old woman who underwent, one year before, to cephalic duodenopancreatectomy complicated with prolonged recurrent vomiting. She underwent to a second surgical operation for intestinal sub-occlusion and postoperatively she developed septic shock and hemorrhagic Wernicke’s disease. After ICU admission, because of neurological deterioration, she underwent CT scan and MRI that highlighted a strong suspicion for Wernicke’s disease. We treated her with an initially wrong low dose of thiamine, then after MRI we increased the dosage with a neurological status improvement. Despite therapeutic efforts used to control septic shock and thrombocytopenia, she died on the 21st day after surgery because of massive cerebral bleeding and unresponsive cerebral edema.
Early detection of subclinical thiamine deficiency is a difficult task, as symptoms may be nonspecific. Wernicke’s disease remains a clinical diagnosis because there are no specific diagnostic abnormalities revealed in cerebrospinal fluid, electroencephalogram or evoked potentials. About this, the best aid for a correct diagnosis is the clinical suspicion and clinicians should consider the disorder in any patients with unbalanced nutrition, increased metabolism or impaired food absorption. A hallmark of our case was the brain hemorrhage in the typical areas of the Wernicke’s disease, maybe triggered by the thrombocytopenia secondary to sepsis. It might be a good clinical practice administer thiamine to all patients presenting with coma or stupor and risk factors related with thiamine deficiency. Any therapeutic delay may result in permanent neurological damage or death.
KeywordsWernicke’s encephalopathy MRI Septic shock Cerebral bleeding
Wernicke’s encephalopathy (WE) is an acute neurological disorder resulting from thiamine deficiency mainly due to alcohol abuse. Other causes reported are: chronic dietetic deficiency, prolonged total parenteral nutrition without thiamine addition, increased nutrients requirements as in trauma or in septic shock . This disease is often under-diagnosed and under-treated being easily confused with other neurological problems especially in critically ill patients. Severe thiamine deficiency is an emerging problem in non-alcoholic patients and it may develop in postoperative surgical patients with risk factors .
We reported a case of a malnourished patient who underwent surgery complicated with septic shock and hemorrhagic WE.
We reported a case of a 46 years old woman admitted to our hospital because of prolonged recurrent vomiting in a severe state of malnutrition. A year before she had been submitted to duodenopancreatectomy because of a stenotic duodenal adenocarcinoma. Immediately, after hospital admission she underwent to a new explorative laparotomy because of worsening symptoms. In this second abdominal surgery she underwent to gastric enteric anastomosis because of sub-occlusion.
Her ability to absorb substances was already compromised by the first operation. During the last year she did not received an adequate nutrition, moreover she had no vitamins supplement in her diet. After the second surgery she was fed by total parenteral nutrition with glucose solutions, amino-acids solutions and vitamins complex (Cernevit – Baxter@ spa, Roma, Italy) commonly administered to post-surgical patients containing 3,51 mg of thiamine.
After five days from the gastric enteric anastomosis, she developed a Pseudomonas Aeruginosa’s severe sepsis with acute renal failure; so, she was transferred to our Intensive Care Unit (ICU). At ICU admission, she was agitated but she still had a normal Glasgow Coma Scale (GCS 15/15). Brain Computed Tomography (CT) scan control was negative and altered neurological status of the patient was imputed to the severe sepsis. Her blood tests showed leucopenia (1680/ml) and thrombocytopenia (34000/μl).
We performed an electroencephalogram (EEG) control that evidenced slow diffused anomalies, without paroxysms or focal signs. During the night she was sedated with benzodiazepines and intubated because of respiratory worsening.
No neurosurgical indications were given for the hemorrhagic brain lesions. So, we increased thiamine dosage up to 250 mg intravenously three times per day. This therapy was prolonged for one week, and after 4 days of high-dose thiamine supplementation neurological status of the patient had a significant improvement despite severe septic shock, she was able to open her eyes spontaneously and she performed simple commands.
Nevertheless, septic shock worsened and thrombocytopenia became refractory to platelets transfusions, hemodynamic instability became unresponsive to vasopressors and liver hypoperfusion worsened. Despite severe efforts used to control septic shock and thrombocytopenia, she died on the 21st day after surgery because of massive cerebral bleeding and unresponsive cerebral edema. The macroscopic autopsy of the brain was not nullifying because intracerebral hemorrhage and severe cerebral edema led to colliquation the typical areas of the Wernicke’s disease.
WE is an acute neurologic syndrome resulting from a deficiency in thiamine, which in its biologically active form (thiamine pyrophosphate) is a cofactor in several biochemical pathways in the brain .
Early detection of subclinical thiamine deficiency is a difficult task, as symptoms may be nonspecific, such as headaches, fatigue, irritability and abdominal discomfort . Definite thiamine deficiency presents with WE, which has an acute onset and is characterized by mental status changes, ocular abnormalities, and gait ataxia . About 82% of patients have mental status changes according to autopsy-based series . Unfortunately, autoptical brain examination in our case couldn’t conclusively demonstrate the typical histological lesions because of massive hemorrhage in the typical anatomical site and severe swelling.
WE remains a clinical diagnosis because there are no specific abnormalities detectable in cerebrospinal fluid, EEG, or evoked potentials. About this, the best aid for a correct diagnosis is only the clinical suspicion and neurologists or intensivists should consider this disorder in any patients with unbalanced nutrition, increased metabolism or impaired food absorption .
We found many risk conditions in our patient: surgical procedures that led to exclusion of portion of the gastrointestinal tract; recurrent vomiting lasting several months associated with intestinal sub-obstruction and malnutrition; systemic disease such as sepsis that affected thiamine intake and metabolism and parenteral nutrition without replacement.
Early diagnosis and treatment of WE is crucial in order to avoid persistent brain damage . The presumptive diagnosis of WE can be confirmed by determining blood thiamine concentrations or by measuring the red blood cell transketolase activity . However, these measurements are limited by a lack of specificity and technical difficulty . Another tool that can help the clinician in WE diagnosis is represented by MRI , altered signal in mammillary bodies and periaqueductal grey. A serious complication of WE is secondary hemorrhage, often associated with poor outcome . In our patient, CT scan and MRI have helped the clinician in identifying the Wernicke’s disease, but severe bleeding in the typical sites has altered the anatomy not allowing a definitive diagnosis. Cerebral bleeding was precipitated by the concomitant presence of the severe thrombocytopenia.
Despite the non-diagnostic certainty of neuroradiological images, the sharp improvement in the neurological state of the patient, after the administration of high doses of thiamine, was significant of metabolic disease such as Wernicke.
So, patients who present with symptoms consistent with WE should be empirically treated with a high dose of thiamine hydrochloride three times per day for 2–3 days. In the case there is no response to therapy, supplementation may be discontinued . Doses of thiamine between 100 mg and 250 mg per day apparently may not restore vitamin status, improve clinical signs, or prevent death [6, 11]. Despite these treatments suggestions, there is uncertainty about standard dosage and duration in clinical practice, because they are based only on observational studies and case series .
Thiamine treatment in our patient was started later because of severe sepsis that masked early neurological signs. At the beginning, our thiamine treatment was inappropriate because we used a low dosage; only after MRI report we modified the therapy and after few days we observed a strong improvement in GCS. A prompt treatment with thiamine might have saved life to our patient.
Our case report confirms that a WE diagnosis, in non-alcoholic patients, is difficult and early radiological images may not be conclusive if hemorrhage masks the typical lesions.
What emerges from our experience is that WE has a variable clinical presentation, and it is good practice to treat with thiamine all patients who present in coma or stupor with risk factors associated with thiamine deficiency. The suggestion that we can draw is that such treatment should be undertaken even if neuro-radiological findings are not conclusive. Any therapeutic delay may result in permanent neurological damage or death; conversely, prompt therapy with thiamine may be a life-saving measure.
Written informed consent was obtained from the next of kin of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
- Osiezagha K, Ali S, Freeman C, Barker NC, Jabeen S, Maitra S, Olagbemiro Y, Richie W, Bailey RK: Thiamine deficiency and delirium. Innov Clin Neurosci. 2013, 10 (4): 26-PubMedPubMed CentralGoogle Scholar
- Francini-Pesenti F, Brocadello F, Manara R, Santelli L, Laroni A, Caregaro L: Wernicke’s syndrome during parenteral feeding: not an unusual complication. Nutrition. 2009, 25 (2): 142-10.1016/j.nut.2008.08.003.PubMedView ArticleGoogle Scholar
- Nardone R, Höller Y, Storti M, Christova M, Tezzon F, Golaszewski S, Trinka E, Brigo F: Thiamine deficiency induced neurochemical, neuroanatomical, and neuropsychological alterations: a reappraisal. ScientificWorldJournal. 2013, ᅟ: ᅟ-Oct 21, 2013:Article ID309143Google Scholar
- Kopelman MD, Thomson AD, Guerrini I, Marshall EJ: The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol. 2009, 44 (2): 148-10.1093/alcalc/agn118.PubMedView ArticleGoogle Scholar
- Harper CG, Giles M, Finlay-Jones R: Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986, 49 (4): 341-10.1136/jnnp.49.4.341.PubMedPubMed CentralView ArticleGoogle Scholar
- Sechi G, Serra A: Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007, 6 (5): 442-10.1016/S1474-4422(07)70104-7.PubMedView ArticleGoogle Scholar
- Dreyfus PM: Clinical application of blood transketolase determinations. N Engl J Med. 1962, 267: 596-10.1056/NEJM196209202671204.PubMedView ArticleGoogle Scholar
- Isenberg-Grzeda E, Kutner HE, Nicolson SE: Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics. 2012, 53 (6): 507-10.1016/j.psym.2012.04.008.PubMedView ArticleGoogle Scholar
- Elefante A, Puoti G, Senese R, Coppola C, Russo C, Tortora F, de Divitiis O, Brunetti A: Non-alcoholic acute Wernicke’s encephalopathy: role of MRI in non typical cases. Eur J Radiol. 2012, 81 (12): 4099-10.1016/j.ejrad.2012.08.006.PubMedView ArticleGoogle Scholar
- Pereira DB, Pereira ML, Gasparetto EL: Nonalcoholic Wernicke encephalopathy with extensive cortical involvement: cortical laminar necrosis and hemorrhage demonstrated with susceptibility-weighted MR phase images. AJNR Am J Neuroradiol. 2011, 32 (2): E37-10.3174/ajnr.A2359.PubMedView ArticleGoogle Scholar
- Cook CC: Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl. 2000, 35 (1): 19-PubMedGoogle Scholar
- Day E, Bentham PW, Callaghan R, Kuruvilla T, George S: Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013, 7: CD004033-PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.